Print Page  |  Close Window

Investors

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs for viral infections and liver diseases. Enanta’s research and development is currently focused on four disease targets: Hepatitis C Virus (HCV), Hepatitis B Virus (HBV), Non-alcoholic Steatohepatitis (NASH) and Respiratory Syncytial Virus (RSV).

Recent News

More News >>

Upcoming Events
Monday, April 3, 2017 4:00 p.m. ET
Enanta Pharmaceuticals Inc at H.C. Wainwright NASH Investor Conference

More Events >>

Stock Quote
ENTA (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$31.25
Change (%) Stock is Down 0.13 (0.41%)
Volume113,126
Data as of 03/28/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.